Wu Jia Pi

Star

Acanthopanax gracilistylus W.W. Smith

Not yet clinically reviewed

Genus: Acanthopanax Species: gracilistylus Pinyin: Wu Jia Pi
Slender Acanthopanax Root Bark五加皮

Traditionally used for

  • Urinary & fluids
  • Pain & joints
  • Energy & fatigue

Cautions & contraindications

  • Toxic — professional use only
Strong evidence · 7 studies

☯ TCM Properties

Category: wind-damp dispelling
Temperature: warm
Taste: pungent, bitter
Meridians: liver, kidney
Functions:

Dispels Wind-Dampness; Nourishes Liver and Kidney Yin; Strengthens the Sinews and Bones; Promotes Urination and Reduces Edema

Traditional Chinese Uses

Wu Jia Pi (acanthopanax bark, eleuthero bark) is a warm herb used to tonify the Liver and Kidney, strengthen bones and sinew, expel Wind-Cold-Damp, and reduce edema. It addresses lower back and knee pain, joint stiffness, and weakness from Liver-Kidney deficiency combined with Wind-Cold-Damp obstruction, making it well suited for elderly patients with both deficiency and joint pathology. Its mild diuretic action also reduces edema. Wu Jia Pi was a traditional ingredient in classical Chinese medicinal wines for chronic weakness and joint pain.

Western Herbalism Properties

Actions:
tonicanti-inflammatorydiuretic

Click a node for details · double-click to expand it · Ctrl/⌘ + scroll or two fingers to zoom and pan.

Loading graph…

Botanical Description

Eleutherococcus gracilistylus (syn. Acanthopanax gracilistylus, Araliaceae), known as Wu Jia Pi, is a deciduous spiny shrub 2-3 m tall with slender, sparingly prickly branches. The palmately compound leaves bear 3-5 obovate to elliptic, finely serrate leaflets 3-8 cm long on long petioles. Small greenish-yellow flowers are arranged in solitary or paired umbels at the branch tips, followed by globose black drupes 6-8 mm across that ripen in autumn. The shrub is native to thickets and forest margins of central and southern China at 200-1600 m elevation. The root bark, peeled from the root in summer or autumn, dried, and cut into rolled or quilled pieces, is the medicinal Wu Jia Pi, distinct from the related Ci Wu Jia (E. senticosus). (Sources: POWO; Wikipedia; Bensky)

Active Constituents

Acankoreagenin

Lupane-type pentacyclic triterpene (sapogenin); also reported as acankoreanogenin and as HLEDA

Concentration: Present in root bark and leaves; the aglycone from which the most abundant glycosylated terpenoids of this species derive. No pharmacopoeial content limit is set for it

The best-characterised anti-inflammatory principle of the drug. It inhibits NF-kappaB activation and shows anti-inflammatory and anti-oedema activity in vitro and in vivo comparable to its analogue impressic acid. It is a triterpene, not a cardioactive steroid, and has no digoxin-like action on the sodium-potassium pump.

Acankoreoside A

Lupane-type triterpenoid saponin (glycoside of acankoreagenin)

Concentration: One of the most abundant glycosylated terpenoids of the species; found in root bark and leaves

A representative of the acankoreoside series that carries most of the saponin content of Acanthopanacis cortex. Reported anti-inflammatory activity, more potent than the related acantrifoside A.

Impressic acid

Lupane-type pentacyclic triterpene

Concentration: Reported from the aerial parts and root of the species

A structural analogue of acankoreagenin that strongly inhibits NF-kappaB signalling and modulates PPAR-gamma target genes. In an osteosarcoma study, impressic acid and a derived 23-nor-3,4-seco-3-acetallupane triterpenoid inhibited cell migration and vasculogenic mimicry in 143B cells.

ent-16beta-H,17-isovalerate-kauran-19-oic acid

Kaurane (kaurenoic acid-type) diterpenoid

Concentration: Quantified together with its positional isomer by validated HPLC-ELSD in 9 batches of Acanthopanacis Cortex; the pair are regarded as the major active diterpenoids of the root bark

One of the two kaurenoic acid isomers used as chemical markers for the root bark. Kaurenoic acid-type diterpenoids are the constituents most often credited with the anti-inflammatory action of the drug, and kaurenoic acid biosynthesis is the pathway that transcriptome work on this species has focused on.

ent-16beta-H,17-methyl butanoate-kauran-19-oic acid

Kaurane (kaurenoic acid-type) diterpenoid

Concentration: The positional isomer of the above, co-quantified in the same 9 batches by HPLC-ELSD

Positional isomerism between these two diterpenoids is the reason quantitative analysis of the drug was slow to develop, and it remains a practical obstacle to standardising Wu Jia Pi material.

Gracilistone A

Eudesmane-type sesquiterpenoid with a tetrahydrofuran-fused 6/6/5 tricyclic skeleton

Concentration: Isolated from the root bark by LC-MS-guided fractionation

Potently inhibits lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophages, with antioxidant and xanthine oxidase inhibitory activity as well. In vitro evidence only.

Chlorogenic acids and other acyl-quinic acids

Phenolic acid esters (caffeoylquinic and related acyl-quinic acids)

Concentration: Identified and quantified in the root bark by UHPLC-Q-Exactive Orbitrap mass spectrometry; 29 acyl-quinic acids including 11 previously undescribed ones have been isolated from the same material

Contribute the antioxidant capacity of the extract, and several of the isolated acyl-quinic acids inhibit neutrophil elastase and cyclooxygenase-2 in vitro. Six of them are unusual oxyneolignan-quinic acid heterodimers, a class first reported from this drug.

Lignans of Acanthopanacis cortex

Lignans

Concentration: Sixteen lignans, four previously undescribed, isolated from the root bark

Eight of the sixteen showed selective cyclooxygenase-2 inhibition with IC50 values from 0.75 to 8.17 µM while only weakly inhibiting cyclooxygenase-1 and neutrophil elastase, which is a plausible mechanistic account of the drug's traditional use in joint disease. This is enzyme-level in vitro data, not clinical data.

Acanthopanax gracilistylus polysaccharide

Heteropolysaccharide

Concentration: Sugar content 43 percent and glucuronic acid content 8.06 percent; composed of mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose and arabinose in molar ratio 0.32:0.15:0.04:0.12:5.12:2.50:0.85

Studied as an immunological adjuvant in a veterinary vaccine model. Included here because it is the one constituent of this drug for which a quantitative compositional analysis has been published.

Cardiac glycosides

Cardenolide steroidal glycosides (absent from this species)

Concentration: Not detected; no cardenolide has been reported from Acanthopanax gracilistylus in the phytochemical literature

Recorded deliberately as a negative. Wu Jia Pi is an Araliaceae root bark whose chemistry is triterpenoid, diterpenoid, sesquiterpenoid, lignan and phenolic acid. It is not cardioactive and has no digoxin-like effect. The cardiac glycosides that practitioners associate with the name Wu Jia Pi belong to Periploca sepium, the Apocynaceae root bark sold as Xiang Jia Pi or Bei Wu Jia Pi, which is a different plant in a different family and is a documented substitute for this drug.

⚠ Drug Interactions

Periploca sepium root bark (Xiang Jia Pi, Bei Wu Jia Pi, Cortex Periplocae)

Major Evidence: Established

This is a substitution hazard, not a pharmacodynamic interaction, and it is the single most important safety fact about this drug. Confusion between Acanthopanax root bark (Wu Jia Pi) and Periploca root bark (Xiang Jia Pi) is documented in the review literature on this species, along with confusion with Hedyotis hedyotidea and Acanthopanax giraldii. The two drugs share the trade name because Periploca sepium is sold regionally as Bei Wu Jia Pi, the northern Wu Jia Pi, against Nan Wu Jia Pi for the genuine Araliaceae drug. Periploca sepium root bark contains the cardenolide cardiac glycosides periplocin, periplocymarin and periplogenin, which inhibit the sodium-potassium ATPase in the same way as digoxin; periplocin is the most cytotoxic constituent of that drug, and pharmacokinetic work in rats tracks periplocin plus periplogenin, periplocymarin, gomphogenin and 17-alpha-asclepioside in cardiac tissue. Acanthopanax gracilistylus contains no cardenolides at all, so the entire cardiotoxic risk associated with the name Wu Jia Pi comes from the substituted drug. Stating this positively matters as much as the warning: correctly identified Wu Jia Pi is not cardioactive and does not interact with digoxin.

Clinical note: Confirm botanical identity before dispensing, particularly for material sourced in northern China. Periploca root bark is strongly aromatic (the xiang in Xiang Jia Pi), with a bitter, prickling taste and a pale yellowish cross-section, whereas the genuine Araliaceae bark is only faintly fragrant. If a patient on Wu Jia Pi presents with nausea, vomiting, visual disturbance, bradycardia or arrhythmia, treat it as suspected cardiac glycoside poisoning and secure and identify the herb, rather than excluding the herb because Wu Jia Pi is not cardioactive.

Digoxin and other cardiac glycosides

Theoretical Evidence: Theoretical

No interaction is expected between digoxin and correctly identified Acanthopanax gracilistylus root bark: the species contains no cardenolide and there is no reported effect on the sodium-potassium ATPase, on P-glycoprotein-mediated digoxin transport, or on digoxin pharmacokinetics. The risk arises entirely from misidentified material. Where Periploca sepium has been supplied as Wu Jia Pi, its cardenolides are additive with digoxin at the same molecular target and will also confound serum digoxin immunoassays, so the interaction is severe rather than moderate in that scenario.

Clinical note: Do not withhold correctly authenticated Wu Jia Pi from a digitalised patient on the mistaken belief that it is cardioactive, and do not assume that a herb labelled Wu Jia Pi is Acanthopanax. The action point is authentication, not avoidance.

Eleutherococcus senticosus (Ci Wu Jia, Acanthopanacis senticosi radix)

Minor Evidence: Probable

A second name-driven confusion, this time between two genuinely related Araliaceae drugs with different profiles and different indications. Wu Jia Pi extracts are sometimes prepared from Acanthopanax senticosus, and eleutherosides, which are the characteristic markers of E. senticosus, are only occasionally found in A. gracilistylus, where eleutheroside D has been identified. Chloroplast genome analysis places E. gracilistylus closer to E. trifoliatus than to E. senticosus. The drugs are not interchangeable and the interaction literature developed for Siberian ginseng, including its reported effects on digoxin assays, should not be transferred to Wu Jia Pi.

Clinical note: Read the botanical name, not the pinyin. Ci Wu Jia is Eleutherococcus senticosus root and is a different drug from Wu Jia Pi, the root bark of Acanthopanax gracilistylus, which is now accepted as Eleutherococcus nodiflorus.

Ethanol (Wu Jia Pi medicinal wine)

Moderate Evidence: Possible

The drug is traditionally taken as Wu Jia Pi Jiu, a medicinal liquor recorded by Li Shizhen. Alcoholic maceration extracts terpenoids far more efficiently than a water decoction, so exposure is not comparable between the two preparations, and self-prepared wines have no dose control. A case report describes striking dark purple discolouration of the intestine found at endoscopy after consumption of Acanthopanax gracilistylus wine.

Clinical note: Ask specifically whether the patient is taking a home-made herbal wine rather than a decoction, and treat the alcohol as part of the dose. The reported intestinal discolouration was an incidental endoscopic finding rather than a described toxicity, but it establishes that this preparation reaches and visibly affects the gut.

Dosage

Form Amount Frequency Duration Population Notes
decoction 5–10 g Daily — — 中国药典 2020 【用法与用量】5~10g。 【性味与归经】辛、苦,温。归肝、肾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence Tier

Strong evidence · 7 studies

Recorded studies by study design, strongest design at the top. This is a study-design tier only, not a GRADE rating: it does not weigh risk of bias, consistency or precision.

Verified: design read from PubMed for a DOI that resolves to the cited paper Unverified: taken from the study's recorded description

Clinical Studies

Botany, traditional usages, phytochemistry, pharmaceutical analysis, and pharmacology of Eleutherococcus nodiflorus (Dunn) S.Y.Hu: A systematic review

Xiaojun Li, Siqi Tang, Jiao Luo, Xiaodan Zhang, Changsoo Yook, Hao Huang, Xiangqian Liu (2023) Journal of Ethnopharmacology systematic review Verified: Systematic review / meta-analysis

The most complete systematic review of this species, published under its currently accepted name Eleutherococcus nodiflorus, which is synonymous with Eleutherococcus gracilistylus and Acanthopanax gracilistylus and corresponds to the drug Wu Jia Pi or Nan Wu Jia Pi. It covers botany, traditional use for dispelling wind-damp, nourishing liver and kidney, diuresis and strengthening sinews and bones, phytochemistry, analytical methods and pharmacology. It is a narrative synthesis of largely preclinical literature; no controlled human trial of the single herb is identified.

The traditional Chinese medicine WuJiaPi (Acanthopanacis cortex) and its main anti-inflammatory terpenoids

Christian Bailly (2021) Longhua Chinese Medicine systematic review

Review of the natural products of Acanthopanacis cortex, concentrating on triterpenoid glycosides. It identifies acankoreagenin as the central anti-inflammatory sapogenin, with the acankoreosides as its abundant glycosides, and impressic acid as a closely related analogue, both acting largely through NF-kappaB inhibition. It also records explicitly that Wu Jia Pi is confused in commerce with Periploca root bark (Xiang Jia Pi) and with Hedyotis hedyotidea and Acanthopanax giraldii, and that adulteration of this drug is not rare. Plant extract cytotoxicity toward HL-60 leukaemia cells was negligible (IC50 above 800 µg/mL).

Identification of lignans as selective cyclooxygenase-2 inhibitors from the extract of Acanthopanacis cortex

Hao-Dong Yang, Yuan-Gui Yang, Zhi-Shu Tang, Kang Ma, Hong-Bo Xu (2024) Phytochemistry in vitro

Sixteen lignans, four of them previously undescribed, were isolated from the root bark and screened against neutrophil elastase, cyclooxygenase-1 and cyclooxygenase-2. All were weak against neutrophil elastase and cyclooxygenase-1, but eight inhibited cyclooxygenase-2 with IC50 values of 0.75 to 8.17 µM, indicating selectivity. Enzyme-level in vitro work in a single laboratory.

Acyl-quinic acids from the root bark of Acanthopanax gracilistylus and their inhibitory effects on neutrophil elastase and cyclooxygenase-2 in vitro

Hao-Dong Yang, Zhi-Shu Tang, Tao-Tao Xue, Ya-Ya Zhu, Zeng-Hu Su, Hong-Bo Xu (2023) Bioorganic Chemistry in vitro

Twenty-nine acyl-quinic acids were isolated from the root bark, eleven of them new, and six were characterised as previously unreported oxyneolignan-quinic acid heterodimers. This is the first report of acyl-quinic acids from Acanthopanacis Cortex. Their inhibition of neutrophil elastase and cyclooxygenase-2 was assessed in vitro.

Cyperane-Type and Related (Nor)Sesquiterpenoids from the Root Bark of Acanthopanax gracilistylus and Their Inhibitory Effects on Nitric Oxide Production

Hong-Bo Xu, Tong-Hua Yang, Pei Xie, Zhi-Shu Tang, Huai-Li Xu, Chong Deng, Yan-Ni Liang, Rui Zhou, Shi-Jun Liu, Yu Zhang (2020) Journal of Natural Products in vitro

An enantiomeric pair of cyperane-type sesquiterpenoids and a bicyclic-lactone norsesquiterpenoid were isolated from the root bark and shown to inhibit nitric oxide production significantly, supporting a sesquiterpenoid contribution to the anti-inflammatory activity of the drug alongside the triterpenoids.

Preparative separation and quantitative determination of two kaurenoic acid isomers in root barks of Acanthopanax gracilistylus

Xin-Xin Xie, Ze-Jing Jiang, Zhi-Hong Cheng, Dao-Feng Chen (2017) Chinese Journal of Natural Medicines in vitro

Two kaurenoic acid-type diterpenoid positional isomers were separated to high purity and a validated HPLC-ELSD method was used to determine both simultaneously in nine batches of Acanthopanacis Cortex. Relevant to practice because it is one of the few quality-control methods published for authenticating and standardising this drug, in a species where positional isomerism had previously blocked quantitative analysis.

CONSUMPTION OF ACANTHOPANAX GRACILISTYLUS WINE LEADS TO DARK PURPLE INTESTINE

Qingqing Lu, Yang Jiang, Jun Mei, Dongya Chen (2022) Gastroenterology Nursing case report

A single reported case of striking dark purple discolouration of the intestine following consumption of Acanthopanax gracilistylus medicinal wine. It is an endoscopic observation in one patient and establishes no causal toxicity, but it is one of very few published human observations on this drug and is the reason the medicinal-wine preparation is flagged separately from the decoction.

Historical Texts

Shen Nong Ben Cao Jing

Han dynasty; received text compiled by about 220 to 280 CE
The earliest recorded use of Wu Jia Pi. The entry establishes the drug's long-standing indication for dispelling pathogenic wind and strengthening the body, which is the traditional basis for its later wind-damp category placement.

Ben Cao Gang Mu

Ming dynasty, 1596; compiled by Li Shizhen, 1518 to 1593
Records Wu Jia Pi Jiu, the medicinal liquor prepared by soaking the root bark, used to invigorate blood and relieve muscle pain. This is the origin of the alcoholic preparation that is still the commonest domestic form of the drug and that concentrates its terpenoids far more than a water decoction.

References

  1. Jianbo Yang, Lingwen Yao, Kaiyan Gong, Kailin Li, Lei Sun, Wei Cai. Identification and Quantification of Chlorogenic Acids from the Root Bark of Acanthopanax gracilistylus by UHPLC-Q-Exactive Orbitrap Mass Spectrometry . ACS Omega (2022) [DOI]
  2. Zhenlin Li, Nan Yao, Hexiu Liu, Jing Zhou, Cong Zhang, Songlin Li, Shihui Qian, Chunfeng Zhang, Zhonglin Yang. Antiosteosarcoma effects of novel 23-nor-3,4-seco-3-acetallupane triterpenoids from Acanthopanax gracilistylus W.W. Smith var. gracilistylus in 143B cells . Fitoterapia (2022) [DOI]
  3. Hao-Dong Yang, Zhi-Shu Tang, Tao-Tao Xue, Huai-Li Xu, Bao-Long Hou, Ya-Ya Zhu, Zeng-Hu Su, Hong-Bo Xu. Monoterpenoids from the root bark of Acanthopanax gracilistylus and their inhibitory effects on neutrophil elastase, 5-lipoxygenase, andcyclooxygenase-2 in vitro . Phytochemistry (2023) [DOI]
  4. Fanjiao Zuo, Peng Zhao, Caixia Li, Yameng Zhu, Ye Shang, Huizi Ouyang, Jun He. Study on differential distribution of cardiac glycoside extract from Periplocae cortex in normal and heart failure rat cardiac tissue . Fitoterapia (2026) [DOI]

This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.

📝 Notes

Public notes from the community and your own private notes on Wu Jia Pi.

No notes yet.

Log in or register to add your own notes.

Back to Herb Database